| 1 |
32541643 | Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial. | 2020 Jun 16 |
1 |
| 2 |
25109475 | Valsartan independent of AT₁ receptor inhibits tissue factor, TLR-2 and -4 expression by regulation of Egr-1 through activation of AMPK in diabetic conditions. | 2014 Oct |
1 |
| 3 |
22158433 | Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis. | 2012 Feb |
1 |
| 4 |
20537748 | Effect of high-dose valsartan on inflammatory and lipid parameters in patients with Type 2 diabetes and hypertension. | 2010 Sep |
2 |
| 5 |
17261957 | Angiotensin II type 1 receptor blockade improves hyperglycemia-induced endothelial dysfunction and reduces proinflammatory cytokine release from leukocytes. | 2007 Jan |
1 |
| 6 |
20409851 | Increased inflammatory biomarkers in hypertensive type 2 diabetic patients: improvement after angiotensin II type 1 receptor blockade. | 2007 May-Jun |
1 |
| 7 |
15131005 | Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component. | 2004 Jun 25 |
1 |
| 8 |
9767420 | The effect of renin-angiotensin system inhibitors on pro- and anti-inflammatory cytokine production. | 1998 Jul |
1 |